Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma

We provide evidence that a member of the human Schlafen (SLFN) family of proteins, SLFN5, is overexpressed in human pancreatic ductal adenocarcinoma (PDAC). Targeted deletion of SLFN5 results in decreased PDAC cell proliferation and suppresses PDAC tumorigenesis in in vivo PDAC models. Importantly,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischietti, Mariafausta, Eckerdt, Frank, Blyth, Gavin T., Arslan, Ahmet D., Mati, William M., Oku, Chidera V., Perez, Ricardo E., Lee-Chang, Catalina, Kosciuczuk, Ewa M., Saleiro, Diana, Beauchamp, Elspeth M., Lesniak, Maciej S., Verzella, Daniela, Sun, Leyu, Fish, Eleanor N., Yang, Guang-Yu, Qiang, Wenan, Platanias, Leonidas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106654/
https://www.ncbi.nlm.nih.gov/pubmed/33846574
http://dx.doi.org/10.1038/s41388-021-01761-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106654/
https://www.ncbi.nlm.nih.gov/pubmed/33846574
http://dx.doi.org/10.1038/s41388-021-01761-1

Ejemplares similares